Activation of Intracellular Complement in Lungs of Patients With Severe COVID-19 Disease Decreases T-Cell Activity in the Lungs

A novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), arose late in 2019, with disease pathology ranging from asymptomatic to severe respiratory distress with multi-organ failure requiring mechanical ventilator support. It has been found that SARS-CoV-2 infection drives...

Descripción completa

Detalles Bibliográficos
Autores principales: Howell, Mark C., Green, Ryan, McGill, Andrew R., Kahlil, Roukiah M., Dutta, Rinku, Mohapatra, Shyam S., Mohapatra, Subhra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652259/
https://www.ncbi.nlm.nih.gov/pubmed/34899680
http://dx.doi.org/10.3389/fimmu.2021.700705

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652259/
https://www.ncbi.nlm.nih.gov/pubmed/34899680
http://dx.doi.org/10.3389/fimmu.2021.700705

Ejemplares similares